The Evolving Promise of Continuous Glucose Monitors
Continuous glucose monitors (CGMs) are becoming an increasingly popular tool for people with diabetes. Combined, there are roughly 5 million…
How a Person’s Race & Ethnicity Affect their T1D Care
New Research Opportunity Coming Soon: T1D Exchange Registry + Big Data
Recently, we published an article titled “Data From Your CGM Could Help Change the Future of T1D Care” which provided…
Data from Your CGM Could Help Change the Future of T1D Care
T1D Exchange is focused on using real-world research to change and improve the healthcare provided to people with type 1…
Latest News on Beta Bionics’s iLet – Interview with interim CEO, Martha Goldberg Aronson
T1D Exchange was recently offered an opportunity to interview Martha Goldberg Aronson, the interim CEO of Beta Bionics. Beta Bionics…
Status Update: Automated Insulin Delivery Devices
The holy grail of insulin delivery for people with diabetes who use insulin is an automated insulin delivery system (AID)…
New Study Results: Perspectives on Video Visits for T1D Care
Digitizing Diabetes Management with T1D Apps
If you’ve lived with type 1 diabetes (T1D) for a long time, you’ve probably noticed how over the years, more…
Meet the Expert: Using T1D Tech to Improve Care
The T1D Exchange Quality Improvement Collaborative (QIC) was established in 2016 — with the support of The Leona M. and…
Status Update: Connected Insulin Delivery Devices
Do these stats surprise you? Of the 1.6 million people with type 1 diabetes in the US,1 only 30 to…
